Veronica Byfield Sköld
Vorstandsvorsitzender bei BioLamina AB
Profil
Veronica Byfield Sköld is currently the Chief Executive Officer at BioLamina AB.
Previously, she worked as the Chief Sales Officer at Clemondo Group AB.
She holds a graduate degree from the Royal Institute of Technology and an undergraduate degree from IHM Business School AB.
Aktive Positionen von Veronica Byfield Sköld
| Unternehmen | Position | Beginn |
|---|---|---|
BioLamina AB
 BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Vorstandsvorsitzender | 01.10.2021 |
Ehemalige bekannte Positionen von Veronica Byfield Sköld
| Unternehmen | Position | Ende |
|---|---|---|
| CLEMONDO GROUP AB | Vertrieb & Marketing | - |
Ausbildung von Veronica Byfield Sköld
| Royal Institute of Technology | Graduate Degree |
| IHM Business School AB | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CLEMONDO GROUP AB | Consumer Non-Durables |
| Private Unternehmen | 1 |
|---|---|
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Health Technology |